Athanor Capital, LP Nkarta, Inc. Transaction History

Athanor Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$23.94 - $36.68 $171,913 - $263,399	-7,181 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$31.33 - $59.61 $19,737 - $37,554	-630 Reduced 8.07%	7,181 $236,000
Q4 2020 Feb 16, 2021	SELL	$27.03 - $75.62 $115,147 - $322,141	-4,260 Reduced 35.29%	7,811 $480,000
Q3 2020 Nov 16, 2020	BUY	$23.52 - $47.9 $283,909 - $578,200	12,071 New	12,071 $363,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $119M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.